In the first merger challenge of the Trump Administration, the U.S. Federal Trade Commission (FTC) recently moved to block the $627 million acquisition of cardiovascular devicemaker Surmodics by private equity firm GTCR BC Holdings (GTCR). While the lawsuit confirms the continuation of aggressive antitrust enforcement under Trump, it appears to break from the Biden Administration’s focus on private equity buyers, proceeding instead along a path focused on more traditional theories of antitrust harm.
Read the full article: A Return to Traditional M&A? Insights from First Merger Challenge of Trump Administration’s Federal Trade Commission //
Source: https://www.jdsupra.com/legalnews/a-return-to-traditional-m-a-insights-5318119/